Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Kerbel, T; Mach, M; Bartunek, A; Coti, I; Bartko, PE; Andreas, M.
Off-label transapical beating-heart transcatheter mitral valve replacement in severe mitral annular calcification.
Multimed Man Cardiothorac Surg. 2022; 2022:
Doi: 10.1510/mmcts.2022.082
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Andreas Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The recent CE mark approval of a novel transapical transcatheter beating-heart replacement system, anchored by an apical pad, expanded the therapeutic options for patients with a significantly diseased mitral valve who are not eligible for conventional surgery. However, this self-expandable bioprosthesis is-despite promising data from the first European real-world experience-not approved for patients with severe mitral annular calcification. In this video tutorial, we provide a step-by-step description of an off-label transapical mitral valve replacement in a patient with severe degenerative mitral valve disease and limited alternative treatment options.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- Mitral Valve - surgery
- Heart Valve Prosthesis Implantation - administration & dosage
- Heart Valve Prosthesis - administration & dosage
- Off-Label Use - administration & dosage
- Treatment Outcome - administration & dosage
- Heart Valve Diseases - surgery
- Calcinosis - surgery
- Cardiac Catheterization - administration & dosage
- Mitral Valve Insufficiency - surgery